Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, ACC

Invitation to Presentation of Sectra's Three-month Interim Report on September 4


LINKÖPING, Sweden, Aug. 23, 2018 /PRNewswire/ -- The international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will publish its interim report for the period May to July 2018 on September 4, 2018. Sectra invites analysts, investors, and the media to attend a teleconference/webcast in conjunction with the publication of the report. 

Publication of the interim report: 8:00 a.m. September 4, 2018

Presentation: 10:00 a.m. September 4, 2018

To participate, call one of the following numbers five to ten minutes before the conference begins:

Sectra management will present the interim report and answer any questions. The presentation will be held in English and can also be followed online at www.sectra.se/irwebcast. A recorded version will be available via this link after the conference.

Approximately 15 minutes before the start, a presentation (PDF document) will be available for download at www.sectra.se/irwebcast. 

Sectra's financial calendar for the 2018/2019 fiscal year 

Further information about Sectra's financial events and interim reports: http://www.sectra.com/investor/calendar/

Subscribe for information 

To subscribe to financial reports, invitations, and information from Sectra via email, please fill in your contact information at www.sectra.com/subscribe.

For further information, please contact:

Helena Pettersson,
Chief Investor Relations Officer Sectra AB, 
ph +46-13-23-52-04,
e-mail [email protected]

Press photos: http://flickr.com/photos/sectramedicalsystems

 

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/sectra/r/invitation-to-presentation-of-sectra-s-three-month-interim-report-on-september-4,c2599413


These press releases may also interest you

at 16:15
Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for...

at 16:05
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences Announces First Quarter 2024 Financial Results
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...

at 16:05
Dexcom Reports First Quarter 2024 Financial Results
DexCom, Inc. today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an...

More news about Health...


News published on and distributed by: